Alcohol and other drug-related stigma is a growing concern. Many organizations have called for a reduction in such stigma through law reform, but there is little sense of how, precisely, this might be achieved. This paper reports on a new method to examine the relationship between stigma and the law and establish a framework that can guide and inform future law reform efforts.
Get full access to this article
View all access options for this article.
References
1.
E.Goffman, Stigma: Notes on the Management of Spoiled Identity (New York: Prentice Hall1963): at 3.
2.
Goffman, supra note 1: at 13.
3.
Goffman, supra note 1: at 12.
4.
B.G.Link and J.C.Phelan, “Conceptualizing Stigma,”Annual Review of Sociology27 (2001) 363-385.
5.
R.Room, “Stigma, Social Inequality and Alcohol and Drug Use,”Drug and Alcohol Review24, no. 2 (2005): 143-155.
6.
AIVL, Why Wouldn’t I Discriminate Against All of Them?” A Report on Stigma and Discrimination Towards the Injecting Drug User Community (Canberra: Australian Injecting and Illicit Drug Users League, 2011); P.W.Corrigan, S.A.Kuwabara and J.O’Shaughnessy, “The Public Stigma of Mental Illness and Drug Addiction: Findings from a Stratified Random Sample,”Journal of Social Work9, no. 2, (2009): 139-147; C.Lloyd, Sinning and Sinned Against: The Stigma-tisation of Problem Drug Users (London: UK Drug Policy Commission (UKDPC), 2010); C.Lloyd, “The Stigmatization of Problem Drug Users: A Narrative Literature review,”Drugs: Education, Prevention, and Policy20, no. 2 (2013): 85-95; P.Radcliffe and A.Stevens, “Are Drug Treatment Services Only for ‘Thieving Junkie Scumbags?’ Drug Users and the Management of Stigmatised Identities,”Social Science & Medicine67, no. 7 (2008): 1065-1073; L.Simmonds and R.Coomber, “Injecting Drug Users: A Stigmatised and Stigmatising Population,”International Journal of Drug Policy20, no. 2 (2009): 121-130; UKDPC, Getting Serious About Stigma: The Problem with Stigmatising Drug Users (London: UK Drug Policy Commission (UKDPC), 2010).
7.
Lloyd, supra note 6.
8.
UKDPC, supra note 6.
9.
Lloyd, supra note 6 (2013).
10.
J.L.Fitzgerald, K.McDonald and M.Klugman, Unspoken but Everpresent: Hepatitis C in a Regional Setting (Melbourne: University of Melbourne, 2004).
United Nations Office on Drugs and Crime, World Drug Report 2016 (United Nations publication, Sales No. E.16. XI.7), available at <https://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf> (last visited November 13, 2017); see also UNAIDS, Do No Harm: Health, Human Rights, and People Who Use Drugs (New York, UNAIDS, 2016).
13.
World Health Assembly, Resolution on Viral Hepatitis2010, WHA 67.6.
14.
World Health Organization, Global Health Sector Strategy on Viral Hepatitis 2016-2021: Towards Ending Viral Hepatitis (Geneva: World Health Organization, 2016): at 42.
15.
World Health Organisation, supra note 14, at 42.
16.
Ministerial Council on Drug Strategy, National Drug Strategy 2010-2015: A Framework for Action on Alcohol, Tobacco and Other Drugs, 2011 (Canberra: Commonwealth of Australia; 2011).
17.
At the time of writing, Australia’s next National Drug Strategy was still under development.
18.
Commonwealth of Australia, Fourth National Hepatitis C Strategy, 2014-2017 (Canberra, Australia, 2014): at 6.
19.
Goffman, supra note 1, at 3.
20.
Goffman, supra note 1, at 3-4.
21.
Goffman, supra note 1, at 4.
22.
S.Fraser and K.Valentine, Substance and Substitution: Methadone Subjects in Liberal Societies (Basingstoke: Palgrave Macmillan, 2008); S.Fraser and K.Seear, Making Disease, Making Citizens: The Politics of Hepatitis C (Aldershot: Ash-gate, 2011).
23.
M.Nussbaum, Hiding from Humanity: Disgust, Shame and the Law (Princeton: Princeton University Press, 2004).
24.
S.Burris, “Stigma and the Law,”The Lancet367, no. 9509 (2006): 529-531.
25.
Room, supra note 5, at 147-148. See also, J.Buchanan, “Tackling Problem Drug Use: A New Conceptual Framework,”Social Work in Mental Health2, no. 2–3 (2004) 117–138; J.Buchanan and L.Young, “The War on Drugs — A War on Drug Users?”Drugs: Education, Prevention and Policy7, no. 4 (2000) 409–422.
See, for example, S.Ahmed, The Cultural Politics of Emotion, 2nd ed. (New York: Routledge2015); J.Butler, Excitable Speech: A Politics of the Performative (New York: Routledge1997).
Problematic terminology remains in use in drug law and drug policy, however, and at times is used by lawyers, sitting magistrates and judges. See, K.Seear and S.Fraser, “Addiction Veri-diction: Gendering Agency in Legal Mobilisations of Addiction Discourse,”Griffith Law Review25, no. 1 (2016): 13-29; K.Seear and S.Fraser, “Beyond Criminal Law: The Multiple Constitution of Addiction in Australian Legislation,”Addiction Research & Theory22, no. 5 (2014a): 438-450; K.Seear and S.Fraser, “The Addict as Victim: Producing the ‘Problem’ of Addiction in Australian Victims of Crime Compensation.”International Journal of Drug Policy25, no. 5 (2014b): 826–835.
31.
Seear and Fraser, supra note 30 (2014a).
32.
Seear and Fraser, supra note 30 (2014a).
33.
A.Mol, The Body Multiple: Ontology in Medical Practice (Durham: Duke University Press, 2002).
34.
Room, supra note 5, at 150.
35.
Room, supra note 5, at 150.
36.
Room, supra note 5, at 150.
37.
Room, supra note 5, at 150.
38.
Burris, supra note 24, at 530.
39.
C.Sunstein, “On the Expressive Function of Law,”University of Pennsylvania Law Review144 (1996): 2021-2024, at 2025.
40.
C.Bacchi, Analysing Policy: What’s the Problem Represented to Be? (Sydney: Pearson Education, 2009).
41.
Seear and Fraser, supra note 30 (2014a).
42.
S.Fraser, K.Pienaar, E.Dilkes-Frayne, D.Moore, R.Kokanovic, C.Treloar, and A.Dunlop, “Addiction Stigma and the Biopolitics of Liberal Modernity: A Qualitative Analysis,”International Journal of Drug Policy44 (2017): 192-201.
43.
Link and Phelan, supra note 4, at 366.
44.
Link and Phelan, supra note 4.
45.
Simmonds and Coomber, supra note 6.
46.
Fraser et al., supra note 43.
47.
A.Kleinman and R.Hall-Clifford, “Stigma: A Social, Cultural and Moral Process,”Journal of Epidemiology and Community Health63, no. 6 (2009): 418-419; Link and Phelan, supra note 4.
48.
J.Butler, “Performative Agency,”Journal of Cultural Economy3, no. 2 (2010): 147; J.Butler, Bodies that Matter: On the Dis-cursive Limits of “Sex” (New York: Routledge, 1993); J.Butler, Gender Trouble: Feminism and the Subversion of Identity (New York: Routledge, 1990).
49.
K.Race, “Framing Responsibility: HIV, Biomedical Prevention, and the Performativity of the Law,”Bioethical Inquiry9, no. 3 (2012): 327-338 at 328.
50.
J.Law, “Collateral Realities,”The Politics of Knowledge (London: Routledge, 2011) at 156.
51.
J. StonePeters, “Legal Performance Good and Bad,”Law, Culture and the Humanities4, no. 2 (2008): 179-200.
52.
Butler, supra note 48 (1990).
53.
Race, supra note 49.
54.
S.Fraser and D.Moore, (eds) The Drug Effect: Health, Crime and Society (Melbourne: Cambridge University Press, 2011).
55.
Fraser et al., supra note 42.
56.
Butler, supra note 48 (1993): at 3.
57.
Goffman, supra note 1, at 155.
58.
Fraser et al., supra note 42, at 195.
59.
Fraser et al., supra note 42, at 199.
60.
The authors also recognize the possibility for stigma to be associated with what they call “specific enactments of intoxication.”
61.
Race, supra note 49, at 328.
62.
Race, supra note 49, at 328.
63.
K.Race, “Drug Effects, Performativity and the Law,”International Journal of Drug Policy22, no. 6 (2011): 410-412, at 411.
64.
P.W.Corrigan, A.C.Watson, A.C.Heyrman, A.Warpinski, G.Gracia, N.Slopen, et al.“Structural Stigma in State Legislation,”Psychiatric Services56, no. 5 (2005): 557-563.
65.
Corrigan et al., supra note 64, at 557.
66.
Corrigan et al., supra note 64, at 558.
67.
Corrigan et al., supra note 64, at 558.
68.
J.Quilter, L.McNamara, K.Seear, and R.Room, “Alcohol and Drug Use and Criminal Law: A National Study of the Significance of “Intoxication” Under Australian legislation,”UNSW Law Journal39, no. 3 (2016a): 913-949; J.Quilter, L.McNamara, K.Seear, and R.Room, “The Definition and Significance of ‘Intoxication in Australian Criminal Law: A Case Study of Queensland’s ‘Safe night out’ legislation,”QUT Law Review16, no. 2 (2016b): 42-58.
